Molbio Diagnostics IPO GMP Today

Molbio Diagnostics Limited is a point-of-care diagnostics company engaged in developing and manufacturing diagnostic technologies for infectious and non-communicable diseases. Its main product is the Truenat platform, a portable molecular diagnostics system comprising the Trueprep nucleic acid extraction device, Truelab real-time PCR analysers, and disease-specific Truenat test kits. As of March 31, 2026, the company offered molecular testing for 30 diseases through 43 assays, including tuberculosis, COVID-19, hepatitis B and C, HIV, and HPV. Through its subsidiaries and collaborations, the company also provides radiology products, digital pathology solutions, and breast health screening devices. Its research and development (R&D) activities are conducted through its wholly owned subsidiary, Bigtec Private Limited, with its R&D unit based in Bengaluru, Karnataka. The company has six manufacturing facilities in India, including two in Goa and others in Bengaluru, Visakhapatnam, and Pune. These facilities manufacture diagnostic devices, test kits, radiology products, and digital pathology scanners.